Ventricular septal defect with congenital mitral valve disease: long-term results of corrective surgery

Saket Agarwal1, Balram Airan, Ujjwal K Chowdhury

  • 1Department of Cardiothoracic Surgery, Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi.

Insights

Surgical repair of ventricular septal defect (VSD) and congenital mitral valve disease is feasible. Careful long-term follow-up is crucial for managing potential mitral valve issues after VSD repair.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Congenital heart disease, including ventricular septal defect (VSD) and mitral valve anomalies, requires complex surgical intervention.
  • This study analyzes outcomes of combined VSD repair and mitral valve surgery.

Purpose of the Study:

  • To evaluate the mortality, morbidity, and long-term outcomes of patients undergoing corrective surgery for VSD with congenital mitral valve disease.
  • To assess the feasibility and effectiveness of mitral valve reconstruction in conjunction with VSD closure.

Main Methods:

  • Retrospective analysis of 69 patients (2 months to 45 years) undergoing VSD repair and mitral valve surgery between 1991 and 2000.
  • VSD repair performed via the right atrium; mitral valve reconstruction or replacement as indicated.
  • Detailed assessment of early and late mortality, morbidity, reoperation rates, and long-term survival.

Main Results:

  • 69 patients underwent combined VSD repair and mitral valve surgery, with 52 having perimembranous/subarterial VSDs.
  • Congenital mitral incompetence (46 patients) and stenosis (23 patients) were common. Mitral valve reconstruction was performed in 65 patients.
  • Early mortality was 8.6% (6 deaths); late mortality was 4 deaths. Actuarial survival at 10 years was 85.0% ± 5.0%, with freedom from reoperation at 45% ± 10.0%.

Conclusions:

  • Mitral valve reconstruction combined with VSD closure is achievable in the majority of cases.
  • Long-term surveillance is essential to monitor for evolving mitral valve dysfunction and other complications post-surgery.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...